MGI GP, Inc.
🏢 View company profile →7Patents
1Active
7Granted
27Portfolio score
Filing activity: Aug 6, 2002 → Aug 6, 2007 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7268138B2 | Compounds, methods and pharmaceutical compositions for inhibiting PARP | Chemistry; Metallurgy | 24 | Expired |
| US7456178B2 | Compounds, methods and pharmaceutical compositions for inhibiting PARP | Chemistry; Metallurgy | 20 | Active |
| US7235557B2 | Compounds and their uses | Chemistry; Metallurgy | 7 | Expired |
| US7307080B2 | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage | Chemistry; Metallurgy | 4 | Expired |
| US7157452B2 | Substituted 4,9-dihydrocyclopenta{imn}phenanthridine-5-ones derivatives thereof and their uses | Chemistry; Metallurgy | 2 | Expired |
| US7229978B2 | Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol | Chemistry; Metallurgy | 0 | Expired |
| US7247641B2 | Compounds, derivatives, compositions, preparation and uses | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.